The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so I think this device is I mean I I really hope that this device gets approved in the US because we'll certainly have every one of our patients wearing this and it would do away with ambulatory blood pressure cuffs which are cumbersome and difficult to use and low compliance and artificial
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so this is a device uh that is not yet FDA approved but it is approved by this similar governing bodies in Europe so this is a device that's already on the market in Europe and it's a it's a bracelet that you wear that optically measures a signal in your wrist and you calibrate it against a manual a pardon me against an automated cuff and um every two hours it gives you kind of your average blood blood pressure